From: Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis
Treatment
Incidence
Day of disease onseta
Mean maximal clinical scorea
Vehicle
100% (8/8)
16.6 ± 0.9
3.8 ± 0.3
Mepazine
33% (3/10)
16.3 ± 1.3
2.1 ± 0.4b